论文部分内容阅读
目的:本次主要对血清β2微球蛋白检验在糖尿病肾病患者中的应用价值进行探究。方法:将2016年11月-2017年4月我院收治糖尿病肾病患者80例患者作为研究对象,将所有患者依照病程差异均分为两组,即A组与B组,其中病程超过五年的患者为A组,而病程低于五年的患者为B组,同期选取于我院健康体检正常人士40例作为C组。三组研究对象均给予血清β2微球蛋白检验,对比分析三组血清β2微球蛋白的水平以及异常情况。结果:A组患者的血清β2微球蛋白水平与异常率均明显高于B组与C组(P<0.05)。结论:血清β2微球蛋白检验对于糖尿病肾病患者诊断具有较高的应用价值。
Objective: The purpose of this study is to investigate the value of serum β2 microglobulin test in patients with diabetic nephropathy. Methods: From November 2016 to April 2017, 80 patients with diabetic nephropathy in our hospital were enrolled in this study. All patients were divided into two groups according to the course of disease: group A and group B, of which over 5 years Patients in group A, while the duration of less than five years in patients with Group B, the same period selected normal hospital physical examination in 40 cases as C group. Three groups of subjects were given serum β2 microglobulin test, comparative analysis of the three groups of serum β2 microglobulin levels and abnormalities. Results: Serum β2 microglobulin level and abnormal rate in group A were significantly higher than those in group B and C (P <0.05). Conclusion: Serum β2 microglobulin test has high value for the diagnosis of patients with diabetic nephropathy.